Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Phase 2 Trial of Once-Weekly Petrelintide Compared With Placebo in Participants With Overweight or Obesity and Type 2 Diabetes

NCT06926842 is registered in ClinicalTrials.gov with Zealand Pharma as lead sponsor.

NCT NCT06926842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06926842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Phase 2 Trial of Once-Weekly Petrelintide Compared With Placebo in Participants With Overweight or Obesity and Type 2 Diabetes
Lead sponsor
Zealand Pharma
Phase
Phase 2
Overall status
Completed
Start date
April 22, 2025
Completion date
August 13, 2026
Enrollment
221 (actual)
Sites
48

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, overweight, type 2 diabetes